Tag Archives: cancer

Naturally occurring DNA segment not patentable: USSC

In a very important decision, the Supreme Court of United States ruled that a naturally occurring deoxyribonucleic acid (DNA) segment is a product of nature and not patent eligible merely because it has been isolated.   The Court, however, ruled … Continue reading

Posted in Intellectual Property Law, International Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Novartis cancer drug patent application rejected for lack of enhancement of efficacy: SC

In a very important ruling, the Supreme Court of India rejected a patent application by Novartis for a major cancer drug on the ground that the application was not an invention per Section 3(d) of the Patent Act. The Court … Continue reading

Posted in Intellectual Property Law, International Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Cipla not infringing Pfizer patent for drug Tarceva: DHC

In a big relief to pharmaceutical company Cipla Ltd. (“Cipla”), the Delhi High Court ruled that Cipla did not infringe OSI/Pfizer (“Pfizer”) Indian patent for their drug ‘Erlotinib’ (trade name ‘Tarceva’) by manufacture, marketing and sale of their drug ‘Erlocip’, … Continue reading

Posted in Intellectual Property Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment